B7x/B7-H4 modulates the adaptive immune response and ameliorates renal injury in antibody-mediated nephritis

R. D. Pawar, Beatrice Goilav, Y. Xia, L. Herlitz, J. Doerner, S. Chalmers, K. Ghosh, Xingxing Zang, Chaim Putterman

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Kidney disease is one of the leading causes of death in patients with lupus and other autoimmune diseases affecting the kidney, and is associated with deposition of antibodies as well as infiltration of T lymphocytes and macrophages, which are responsible for initiation and/or exacerbation of inflammation and tissue injury. Current treatment options have relatively limited efficacy; therefore, novel targets need to be explored. The co-inhibitory molecule, B7x, a new member of the B7 family expressed predominantly by non-lymphoid tissues, has been shown to inhibit the proliferation, activation and functional responses of CD4 and CD8 T cells. In this study, we found that B7x was expressed by intrinsic renal cells, and was up-regulated upon stimulation with inflammatory triggers. After passive administration of antibodies against glomerular antigens, B7x-/- mice developed severe renal injury accompanied by a robust adaptive immune response and kidney up-regulation of inflammatory mediators, as well as local infiltration of T cells and macrophages. Furthermore, macrophages in the spleen of B7x-/- mice were polarized to an inflammatory phenotype. Finally, treatment with B7x-immunoglobulin (Ig) in this nephritis model decreased kidney damage and reduced local inflammation. We propose that B7x can modulate kidney damage in autoimmune diseases including lupus nephritis and anti-glomerular basement membrane disease. Thus, B7x mimetics may be a novel therapeutic option for treatment of immune-mediated kidney disease.

Original languageEnglish (US)
Pages (from-to)329-343
Number of pages15
JournalClinical and Experimental Immunology
Volume179
Issue number2
DOIs
StatePublished - Feb 1 2015

Fingerprint

Nephritis
Adaptive Immunity
Kidney
Antibodies
Wounds and Injuries
Macrophages
Kidney Diseases
T-Lymphocytes
Autoimmune Diseases
Anti-Glomerular Basement Membrane Disease
Inflammation
Lupus Nephritis
Therapeutics
Immunoglobulins
Cause of Death
Up-Regulation
Spleen
Phenotype
Antigens

Keywords

  • B7x
  • Co-inhibition
  • Co-stimulation
  • Nephritis
  • T cells

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

B7x/B7-H4 modulates the adaptive immune response and ameliorates renal injury in antibody-mediated nephritis. / Pawar, R. D.; Goilav, Beatrice; Xia, Y.; Herlitz, L.; Doerner, J.; Chalmers, S.; Ghosh, K.; Zang, Xingxing; Putterman, Chaim.

In: Clinical and Experimental Immunology, Vol. 179, No. 2, 01.02.2015, p. 329-343.

Research output: Contribution to journalArticle

@article{f303ca2f62f0434bb0c211b858574150,
title = "B7x/B7-H4 modulates the adaptive immune response and ameliorates renal injury in antibody-mediated nephritis",
abstract = "Kidney disease is one of the leading causes of death in patients with lupus and other autoimmune diseases affecting the kidney, and is associated with deposition of antibodies as well as infiltration of T lymphocytes and macrophages, which are responsible for initiation and/or exacerbation of inflammation and tissue injury. Current treatment options have relatively limited efficacy; therefore, novel targets need to be explored. The co-inhibitory molecule, B7x, a new member of the B7 family expressed predominantly by non-lymphoid tissues, has been shown to inhibit the proliferation, activation and functional responses of CD4 and CD8 T cells. In this study, we found that B7x was expressed by intrinsic renal cells, and was up-regulated upon stimulation with inflammatory triggers. After passive administration of antibodies against glomerular antigens, B7x-/- mice developed severe renal injury accompanied by a robust adaptive immune response and kidney up-regulation of inflammatory mediators, as well as local infiltration of T cells and macrophages. Furthermore, macrophages in the spleen of B7x-/- mice were polarized to an inflammatory phenotype. Finally, treatment with B7x-immunoglobulin (Ig) in this nephritis model decreased kidney damage and reduced local inflammation. We propose that B7x can modulate kidney damage in autoimmune diseases including lupus nephritis and anti-glomerular basement membrane disease. Thus, B7x mimetics may be a novel therapeutic option for treatment of immune-mediated kidney disease.",
keywords = "B7x, Co-inhibition, Co-stimulation, Nephritis, T cells",
author = "Pawar, {R. D.} and Beatrice Goilav and Y. Xia and L. Herlitz and J. Doerner and S. Chalmers and K. Ghosh and Xingxing Zang and Chaim Putterman",
year = "2015",
month = "2",
day = "1",
doi = "10.1111/cei.12452",
language = "English (US)",
volume = "179",
pages = "329--343",
journal = "Clinical and Experimental Immunology",
issn = "0009-9104",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - B7x/B7-H4 modulates the adaptive immune response and ameliorates renal injury in antibody-mediated nephritis

AU - Pawar, R. D.

AU - Goilav, Beatrice

AU - Xia, Y.

AU - Herlitz, L.

AU - Doerner, J.

AU - Chalmers, S.

AU - Ghosh, K.

AU - Zang, Xingxing

AU - Putterman, Chaim

PY - 2015/2/1

Y1 - 2015/2/1

N2 - Kidney disease is one of the leading causes of death in patients with lupus and other autoimmune diseases affecting the kidney, and is associated with deposition of antibodies as well as infiltration of T lymphocytes and macrophages, which are responsible for initiation and/or exacerbation of inflammation and tissue injury. Current treatment options have relatively limited efficacy; therefore, novel targets need to be explored. The co-inhibitory molecule, B7x, a new member of the B7 family expressed predominantly by non-lymphoid tissues, has been shown to inhibit the proliferation, activation and functional responses of CD4 and CD8 T cells. In this study, we found that B7x was expressed by intrinsic renal cells, and was up-regulated upon stimulation with inflammatory triggers. After passive administration of antibodies against glomerular antigens, B7x-/- mice developed severe renal injury accompanied by a robust adaptive immune response and kidney up-regulation of inflammatory mediators, as well as local infiltration of T cells and macrophages. Furthermore, macrophages in the spleen of B7x-/- mice were polarized to an inflammatory phenotype. Finally, treatment with B7x-immunoglobulin (Ig) in this nephritis model decreased kidney damage and reduced local inflammation. We propose that B7x can modulate kidney damage in autoimmune diseases including lupus nephritis and anti-glomerular basement membrane disease. Thus, B7x mimetics may be a novel therapeutic option for treatment of immune-mediated kidney disease.

AB - Kidney disease is one of the leading causes of death in patients with lupus and other autoimmune diseases affecting the kidney, and is associated with deposition of antibodies as well as infiltration of T lymphocytes and macrophages, which are responsible for initiation and/or exacerbation of inflammation and tissue injury. Current treatment options have relatively limited efficacy; therefore, novel targets need to be explored. The co-inhibitory molecule, B7x, a new member of the B7 family expressed predominantly by non-lymphoid tissues, has been shown to inhibit the proliferation, activation and functional responses of CD4 and CD8 T cells. In this study, we found that B7x was expressed by intrinsic renal cells, and was up-regulated upon stimulation with inflammatory triggers. After passive administration of antibodies against glomerular antigens, B7x-/- mice developed severe renal injury accompanied by a robust adaptive immune response and kidney up-regulation of inflammatory mediators, as well as local infiltration of T cells and macrophages. Furthermore, macrophages in the spleen of B7x-/- mice were polarized to an inflammatory phenotype. Finally, treatment with B7x-immunoglobulin (Ig) in this nephritis model decreased kidney damage and reduced local inflammation. We propose that B7x can modulate kidney damage in autoimmune diseases including lupus nephritis and anti-glomerular basement membrane disease. Thus, B7x mimetics may be a novel therapeutic option for treatment of immune-mediated kidney disease.

KW - B7x

KW - Co-inhibition

KW - Co-stimulation

KW - Nephritis

KW - T cells

UR - http://www.scopus.com/inward/record.url?scp=84920275729&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920275729&partnerID=8YFLogxK

U2 - 10.1111/cei.12452

DO - 10.1111/cei.12452

M3 - Article

VL - 179

SP - 329

EP - 343

JO - Clinical and Experimental Immunology

JF - Clinical and Experimental Immunology

SN - 0009-9104

IS - 2

ER -